Marketing-authorisation holder
Bio Agri Mix Lp
112 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1β25 of 112
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 2 SULFAMED630 mg / g + 315 mg / g Β· Powder For Solution | Sulfamethazine, Sulfathiazole | Canada | Marketed | 1993 |
| AMOXICILLIN SP800 mg / g Β· Powder | Amoxicillin | Canada | Marketed | 2016 |
| AMPROLIUM 250250 G / Kg Β· Drug Premix | Amprolium | Canada | Marketed | 2023 |
| AMPROLIUM SOLUTION9.6 % / w/v Β· Solution | Amprolium | Canada | Marketed | 2023 |
| BACITRACIN MD110 G / Kg Β· Drug Premix | Bacitracin | Canada | Marketed | 2013 |
| BACITRACIN MD SOLUBLE440 mg / g Β· Powder For Solution | Bacitracin | Canada | Authorised | |
| CEFTIOFUR SODIUM FOR INJECTION50 mg / ml Β· Powder For Solution | Ceftiofur | Canada | Marketed | 2026 |
| CHLOR 100220 G / Kg Β· Drug Premix | Chlortetracycline | Canada | Marketed | 1994 |
| CHLOR 50110 G / Kg Β· Drug Premix | Chlortetracycline | Canada | Marketed | 1985 |
| LINCOMYCIN 110110 G / Kg Β· Drug Premix | Lincomycin | Canada | Not marketed | 1994 |
| LINCOMYCIN 110 G110 G / Kg Β· Drug Premix | Lincomycin | Canada | Marketed | 2018 |
| LINCOMYCIN 4444 G / Kg Β· Drug Premix | Lincomycin | Canada | Not marketed | 1994 |
| LINCOMYCIN 44 G44 G / Kg Β· Drug Premix | Lincomycin | Canada | Marketed | 1995 |
| LINCOMYCIN SOLUBLE POWDER400 mg / g Β· Powder | Lincomycin | Canada | Marketed | 1998 |
| LINCOMYCIN SPECTINOMYCIN 100 SOLUBLE POWDER33.3 g / 150 g + 66.6 g / 150 g Β· Powder For Solution | Lincomycin, Spectinomycin | Canada | Marketed | 1998 |
| LINCOMYCIN SPECTINOMYCIN 4.4% G PREMIX22 G / Kg + 22 G / Kg Β· Drug Premix | Lincomycin, Spectinomycin | Canada | Marketed | 1996 |
| MONENSIN PREMIX200 G / Kg Β· Drug Premix | Monensin | Canada | Marketed | 2001 |
| NEO-CHLOR20 g / 100 g + 20 g / 100 g Β· Powder For Solution | Neomycin, Tetracycline | Canada | Not marketed | 1982 |
| NEO-TETRAMED200 mg / g + 200 mg / g Β· Powder For Solution | Neomycin, Tetracycline | Canada | Marketed | 1993 |
| NEOMED 32556.875 g / 100 g Β· Powder For Solution | Neomycin | Canada | Marketed | 1993 |
| NICARBAZIN 250 G250 G / Kg Β· Drug Premix | Nicarbazin | Canada | Marketed | 2025 |
| OXYSOL-110110 G / Kg Β· Drug Premix | Oxytetracycline | Canada | Not marketed | 1994 |
| OXYSOL-220220 G / Kg Β· Drug Premix | Oxytetracycline | Canada | Not marketed | 1997 |
| OXYSOL-440440 G / Kg Β· Drug Premix | Oxytetracycline | Canada | Not marketed | 1986 |
| OXYSOL-440440 G / Kg Β· Drug Premix | Oxytetracycline | Canada | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 112 | 56 | 56 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- All other non-therapeutic productsVarious Β· ATC V07A
- VitaminsAlimentary tract and metabolism Β· ATC A11A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- bio agri mix
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 112
- Countries
- 1
- Roles
- Authorisation holder



